TOMS founder describes incorrect bipolar diagnosis following $400 million sale
Blake Mycoskie says he received a wrong psychiatric diagnosis after selling his shoe company, an experience that nearly derailed his life.
SOURCE: MarketWatch ↗
What This Means
This is a personal narrative commentary rather than market reporting. Mycoskie describes a health crisis following his company's sale, a high-profile exit that occurred in 2014 when Berkshire Hathaway and other investors acquired majority stake in TOMS. The piece does not establish new information about TOMS, market conditions, or business developments; it is memoir-style reflection on personal experience during and after a major transaction.
Sources — 1 tier
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- MarketWatchOct 1, 2026Read the original report at MarketWatch ↗
SPONSORED
Confidence History
- MEDIUM CONFIDENCEOct 1, 2026 at 12:04 PM
Single-tier claim only (mainstream) -- no independent corroboration yet